Logo
D

DeckTherapeutics, Inc.

4 employees

DeckTherapeutics specializes in acute omega-3 fatty acid therapeutics for neuroprotection.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Hypoxic-ischemic injury
Omega-3
Neonatal
Orphan drugs
Hypoxia-ischemia
Therapeutics
EPA
Neuroprotection
Chemical
Diglyceride
Cerebral palsy
Rare pediatric disease
DHA
Epilepsy

Date founded

2019

FAQ